Martin S. Maron

Martin S. Maron

Cardiology | Radiology

41 Mall Rd
Burlington, MA 01805

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 356 publications

Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association.

Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association.

Journal: Journal of the American College of Cardiology

Published: September 04, 2026

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Journal: Circulation

Published: August 29, 2026

Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Journal: The New England journal of medicine

Published: August 28, 2026

Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM.

Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM.

Journal: Circulation

Published: August 28, 2026

International Experience With Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

International Experience With Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

Journal: Circulation

Published: August 25, 2026

Clinical Course and Predictors of Heart Failure in Asymptomatic Obstructive Hypertrophic Cardiomyopathy.

Clinical Course and Predictors of Heart Failure in Asymptomatic Obstructive Hypertrophic Cardiomyopathy.

Journal: Journal of the American Heart Association

Published: July 03, 2026

Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.

Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.

Journal: JAMA cardiology

Published: June 17, 2026

Best practices in specialized hypertrophic cardiomyopathy centers in the United States: a survey of cardiologists, nurses, pharmacists, patients, and patient advocates.

Best practices in specialized hypertrophic cardiomyopathy centers in the United States: a survey of cardiologists, nurses, pharmacists, patients, and patient advocates.

Journal: Future cardiology

Published: June 11, 2026

The Threshold for a Clinically Meaningful Improvement in Cardiopulmonary Exercise Testing Measures for Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy.

The Threshold for a Clinically Meaningful Improvement in Cardiopulmonary Exercise Testing Measures for Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy.

Journal: Journal of cardiac failure

Published: June 10, 2026

Efficacy of Aficamten vs Metoprolol According to Pretrial Beta-Blocker Treatment in Obstructive Hypertrophic Cardiomyopathy: Insights From MAPLE-HCM.

Efficacy of Aficamten vs Metoprolol According to Pretrial Beta-Blocker Treatment in Obstructive Hypertrophic Cardiomyopathy: Insights From MAPLE-HCM.

Journal: JACC. Heart failure

Published: June 08, 2026

Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Still Highly Relevant (and Innovating) After 65 Years.

Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Still Highly Relevant (and Innovating) After 65 Years.

Journal: Journal of the American College of Cardiology

Published: May 12, 2026

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.

Journal: JAMA

Published: May 11, 2026

Showing 1-12 of 356

Last Updated: 09/26/2026